BiVictriX Therapeutics Plc 4DE.F Stock
BiVictriX Therapeutics Plc Price Chart
BiVictriX Therapeutics Plc 4DE.F Financial and Trading Overview
| BiVictriX Therapeutics Plc stock price | 0.13 EUR |
| Previous Close | 0.15 EUR |
| Open | 0.15 EUR |
| Bid | 0.15 EUR x N/A |
| Ask | 0.18 EUR x N/A |
| Day's Range | 0.15 - 0.15 EUR |
| 52 Week Range | 0.14 - 0.25 EUR |
| Volume | N/A |
| Avg. Volume | 0 EUR |
| Market Cap | 10.76M EUR |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.04 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
4DE.F Valuation Measures
| Enterprise Value | 6.93M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 2.5000002 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -2.366 |
Trading Information
BiVictriX Therapeutics Plc Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -35.89% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.25 EUR |
| 52 Week Low | 0.14 EUR |
| 50-Day Moving Average | 0.15 EUR |
| 200-Day Moving Average | 0.18 EUR |
4DE.F Share Statistics
| Avg. Volume (3 month) | 0 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 66.12M |
| Float | 27.06M |
| Short Ratio | N/A |
| % Held by Insiders | 31.91% |
| % Held by Institutions | 38.15% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -32.57% |
| Return on Equity (ttm) | -48.56% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -2927000 EUR |
| Net Income Avi to Common (ttm) | -2497000 EUR |
| Diluted EPS (ttm) | -0.04 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 3.29M EUR |
| Total Cash Per Share (mrq) | 0.05 EUR |
| Total Debt (mrq) | 295K EUR |
| Total Debt/Equity (mrq) | 7.46 EUR |
| Current Ratio (mrq) | 10.141 |
| Book Value Per Share (mrq) | 0.06 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -2397000 EUR |
| Levered Free Cash Flow (ttm) | -2193375 EUR |
Profile of BiVictriX Therapeutics Plc
| Country | Germany |
| State | N/A |
| City | Macclesfield |
| Address | Alderley Park |
| ZIP | SK10 4TG |
| Phone | N/A |
| Website | https://www.bivictrix.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 17 |
BiVictriX Therapeutics Plc, a biotechnology company, engages in the development of cancer therapies in the United Kingdom. The company develops Bi-Cygni therapeutics, which are selective for cancer types. Its lead program is BVX001, focuses on acute myeloid leukaemia, as well as develops BVX002 and BVX003 for various blood cancers and solid tumours. BiVictriX Therapeutics Plc was founded in 2016 and is headquartered in Macclesfield, the United Kingdom.
Q&A For BiVictriX Therapeutics Plc Stock
What is a current 4DE.F stock price?
BiVictriX Therapeutics Plc 4DE.F stock price today per share is 0.13 EUR.
How to purchase BiVictriX Therapeutics Plc stock?
You can buy 4DE.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for BiVictriX Therapeutics Plc?
The stock symbol or ticker of BiVictriX Therapeutics Plc is 4DE.F.
Which industry does the BiVictriX Therapeutics Plc company belong to?
The BiVictriX Therapeutics Plc industry is Biotechnology.
How many shares does BiVictriX Therapeutics Plc have in circulation?
The max supply of BiVictriX Therapeutics Plc shares is 87.77M.
What is BiVictriX Therapeutics Plc Price to Earnings Ratio (PE Ratio)?
BiVictriX Therapeutics Plc PE Ratio is now.
What was BiVictriX Therapeutics Plc earnings per share over the trailing 12 months (TTM)?
BiVictriX Therapeutics Plc EPS is -0.04 EUR over the trailing 12 months.
Which sector does the BiVictriX Therapeutics Plc company belong to?
The BiVictriX Therapeutics Plc sector is Healthcare.